• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

AtaiBeckley Inc (ATAI)

Common Shares
Sell: $3.97|Buy: $4.00|Change: 0.55 (-12.22%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Address




Website

https://www.ataibeckley.com

Sector 

Healthcare

Forecast key dates

NameKey Date
AtaiBeckley Inc First Quarter Earnings Results for 20272027-05-12T00:00:00
AtaiBeckley Inc Annual General Meeting for 20272027-05-04T11:00:00
AtaiBeckley Inc Fourth Quarter Earnings Results for 20262027-03-05T00:00:00
AtaiBeckley Inc Annual Report for 20262027-03-05T00:00:00
Atai Beckley NV Third Quarter Earnings Results for 20262026-11-12T00:00:00
ATAI Life Sciences NV Second Quarter Earnings Results for 20262026-08-14T00:00:00
UBS Virtual CNS Day2026-06-15T16:30:00
7th Annual HCW Neuro Perspectives Hybrid Conference2026-06-15T07:00:00
Oppenheimer CNS and Neuro-Muscular Summit2026-06-10T13:35:00
Jefferies Global Healthcare Conference2026-06-03T12:15:00

Previous key dates

NameKey Date
UBS Virtual CNS Day2026-06-15T16:30:00
7th Annual HCW Neuro Perspectives Hybrid Conference2026-06-15T07:00:00
Oppenheimer CNS and Neuro-Muscular Summit2026-06-10T13:35:00
Jefferies Global Healthcare Conference2026-06-03T12:15:00
AtaiBeckley Inc First Quarter Earnings Results for 20262026-05-12T00:00:00
AtaiBeckley Inc Annual General Meeting for 20262026-05-04T11:00:00
Leerink Global Healthcare Conference2026-03-11T08:00:00
Virtual Investor Day2026-03-06T09:00:00
AtaiBeckley Inc Fourth Quarter Earnings Results for 20252026-03-06T00:00:00
AtaiBeckley Inc Annual Report for 20252026-03-06T00:00:00
TD Cowen 46th Annual Health Care Conference2026-03-04T11:50:00
Jefferies Global Healthcare Conference2025-11-20T06:30:00
Atai Beckley NV Third Quarter Earnings Results for 20252025-11-12T00:00:00
BPL-003 Phase 2b Open-Label Extension Data2025-11-10T08:00:00
TD Cowen 5(th) Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Su2025-09-17T10:00:00
H.C. Wainwright 27(th) Annual Global Investment Conference2025-09-08T11:30:00
Cantor Global Healthcare Conference 20252025-09-05T08:35:00
ATAI Life Sciences NV Second Quarter Earnings Results for 20252025-08-14T00:00:00
H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference2025-06-17T07:00:00
Jefferies Global Healthcare Conference2025-06-05T09:55:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.